跳至主要内容
临床试验/EUCTR2004-004545-18-BE
EUCTR2004-004545-18-BE进行中(未招募)不适用

Cell therapy for cardiac repair through mobilization of hematopoietic stem cells and endothelial progenitors in patients with chronic ischemic cardiomyopathy. - NA

CHU Sart Tilman0 个研究点目标入组 24 人开始时间: 2005年12月12日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Stable chronic ischemic cardiopathy
  • - Optimal drug treatment
  • - No possible cardiac surgery or angioplasty
  • - NYHA class II-IV
  • - Left ventricular ejection fraction <40%
  • - Collateral circulation and/or hibernating myocardium
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Inclusion criteria not fully met
  • - Previous neoplasia (except in situ cervical cancer or non-melanoma skin cancer)
  • - HIV, HBsAg or HC positive status
  • - Hematological condition potentially impairing response to haematopoietic growth factors
  • - Active infection or inflammatory disorder
  • - Uncontrolled hypertension
  • - Allergy to G-CSF or EPO
  • - Hb >16 g/dl
  • - Blood transfusion dependance

研究者

发起方
CHU Sart Tilman

相似试验